Mom furious at 'reckless' anti-vax parents after baby's possible measles exposure in hospital
Parents fear their baby — who was born a month early and is turning a year old today — might have been exposed to measles during a visit to B.C. Children's Hospital emergency room earlier this month. The family is in isolation in their home on a day they wanted to greet people for Max Seccia-Smith's birthday celebration.
Vincent and Rich return to the University of Texas Medical Branch at Galveston to speak with Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver about their work on viruses transmitted by mosquitoes and ticks. Hosts: Vincent Racaniello and Rich Condit Guests: Dennis Bente, Shannan Rossi, Nikos Vasilakis, and Scott Weaver Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Measles virus vectored chikungunya vaccine (J Inf Dis) World Reference Center for Emerging Viruses and Arboviruses Insect-specific alphavirus vaccine vect...
CONCLUSION: Our results demonstrated lower than expected seroprotection against measles among vaccinated children. Understanding the factors that affect host immunity to measles will aid in developing more efficient and effective immunization programs in DRC. PMID: 32057333 [PubMed - in process]
Bacterial, viral, or overall infection was associated with increased Parkinson's disease risk.Helicobacter pylori, hepatitis C virus, Malassezia, and pneumoniae infection were positively associated with the risk of Parkinson's disease. However, infection of herpes virus, hepatitis B virus, pertussis, scarlet fever, mumps, chicken pox, influenza virus, measles, and German measles was not. AbstractAimsRecent studies showed that patients with various bacterial, viral, and fungal infections might be at increased risk of Parkinson's disease (PD). However, the risk of PD in patients with each specific infection varied. This meta...
By Margarite Nathe, Principal Editor/Writer, IntraHealth International Midwives and nurses —like Sellyvine (left) at the women's hospital in Nakuru, Kenya —make up 50% of the health workforce worldwide. They're in the spotlight during 2020 and will play a crucial role in whether their countries can achieve their most ambitious health targets by 2030. Photo by Georgina Goodwin for IntraHealth International.February 14, 2020Every year, we look at the top global health issues coming our way in the next 12 months. But global health is a long game and it’s a brand-new decade, so this year, we’re look...
[Addis Standard] A total of more than 12 thousand cases of measles were reported in 36 zones of 5 regions of Ethiopia in the past 13 months beginning January 2019, according to the UN. "Oromia region bore the brunt of the outbreaks, with 67 per cent of cases, followed by Somali with 21 per cent," the UN added.
This NIHR Signal pooled data from 56 studies and found that the vaccine is around 58% effective when administered before nine months compared with 83% after nine months.With measles on the rise in Europe and the UK, it is helpful to know that in the event of a measles outbreak, it could be used safely in younger infants as an additional measure.
This House of Lords Library Briefing focuses on the measles, mumps and rubella (MMR) jab. It looks at social media's role in the spread of misinformation, what the UK Government and social media companies have pledged to do about it, and what other countries are doing to solve declining rates of MMR vaccination.
Conclusions: Our study revealed heterogeneity across HDs' mumps outbreak responses but also identified common challenges that will inform future Centers for Disease Control and Prevention guidance. These results were considered in the October 2017 Advisory Committee on Immunization Practices recommendation for use of a third dose of MMR vaccine for persons at increased risk for mumps during an outbreak and in the development of Centers for Disease Control and Prevention guidance for HDs when applying the Advisory Committee on Immunization Practices recommendation.
Conclusion: This guidance provides a framework for public health authorities to use when considering a third dose of MMR in response to mumps outbreaks while maintaining flexibility to incorporate local factors related to individual outbreaks.